Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina.
about
Recent insights into the mechanisms of vasospastic anginaPharmacological reversal of endothelin-1 mediated constriction of the spiral modiolar artery: a potential new treatment for sudden sensorineural hearing loss.The Function of Rho-Associated Kinases ROCK1 and ROCK2 in the Pathogenesis of Cardiovascular DiseaseROCKs as immunomodulators of strokeMetabolic actions of Rho-kinase in periphery and brainLittle ROCK is a ROCK1 pseudogene expressed in human smooth muscle cellsFasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophyNew approaches to the treatment of pulmonary hypertension: from bench to bedside.Gene variations of ROCKs and risk of ischaemic stroke: the Women's Genome Health Study.Coronary artery spasm: Current knowledge and residual uncertainties.Recent achievements in the management of Raynaud's phenomenon.Rho-associated kinase activity is a predictor of cardiovascular outcomes.Coronary spasm that caused non-ST elevation myocardial infarction appeared in cath lab due to vasovagal reactionRho kinase: an important mediator of atherosclerosis and vascular disease.Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction.Increased leukocyte rho kinase (ROCK) activity and endothelial dysfunction in cigarette smokersFailure of Bay K 8644 to induce RhoA kinase-dependent calcium sensitization in rabbit blood vessels.Coronary artery spasm: review and update.Myosin phosphatase-Rho interacting protein. A new member of the myosin phosphatase complex that directly binds RhoA.Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.RhoA/Rho-kinase and vascular diseases: what is the link?Current advances in the understanding of coronary vasospasm.M-RIP targets myosin phosphatase to stress fibers to regulate myosin light chain phosphorylation in vascular smooth muscle cells.Fasudil protects the heart against ischemia-reperfusion injury by attenuating endoplasmic reticulum stress and modulating SERCA activity: the differential role for PI3K/Akt and JAK2/STAT3 signaling pathways.Association analysis of polymorphisms in ROCK2 with cardiovascular disease in a Chinese population.Metabotropic Ca(2+) channel-induced Ca(2+) release and ATP-dependent facilitation of arterial myocyte contractionTargeting Rho-GTPases in immune cell migration and inflammation.Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease.Compressive stress induces dephosphorylation of the myosin regulatory light chain via RhoA phosphorylation by the adenylyl cyclase/protein kinase A signaling pathway.Rho-kinase inhibition attenuates calcium-induced contraction in β-escin but not Triton X-100 permeabilized rabbit femoral arteryCritical role of exogenous nitric oxide in ROCK activity in vascular smooth muscle cells.Rho kinase as a therapeutic target in cardiovascular disease.Rnd3 regulates lung cancer cell proliferation through notch signalingEnhanced expression of ROCK in left atrial myocytes of mitral regurgitation: a potential mechanism of myolysis.Direct inhibition of myosin II effectively blocks glioma invasion in the presence of multiple motogens.Calycosin-7-O-β-D-glucoside promotes oxidative stress-induced cytoskeleton reorganization through integrin-linked kinase signaling pathway in vascular endothelial cellsIncreased leukocyte Rho-associated coiled-coil containing protein kinase activity predicts the presence and severity of coronary vasospastic angina.Cerebral Perfusion Enhancing Interventions: A New Strategy for the Prevention of Alzheimer Dementia.Rho-associated kinase 2 polymorphism of vasospastic angina in korean populationROCKs as therapeutic targets in cardiovascular diseases
P2860
Q24651247-0DA987CC-5958-4C99-9773-131E8F85DC0FQ24812464-0A522DB6-EA8A-490C-9FB0-A59D6EA34116Q26774795-D1C32415-BF87-40AA-9A10-3CCCE2A43F8EQ26853214-1747C52D-06D2-48AD-ADD2-E9B20054ECB2Q26864028-69AD3F37-0297-4D0F-A5BA-81F4F075A69BQ28752240-07A6A3CE-C12E-45CE-A3B4-894EC1C7823BQ30511954-02AEEB2D-D355-4764-BB50-F4897EFAFA4EQ33690368-95F05DFC-AC66-4811-AB70-939F2AE88C10Q33764027-E4578E71-EEF0-4616-8CCA-153231A47978Q33773703-9B665DC4-7281-42E0-804F-A47102B7537EQ33797622-4F3CCDA1-0DD5-471F-B0C7-8FEBA61C7DF7Q33911873-BDD179C8-6319-4698-84BC-309BDE2F4EDAQ33941337-8DDECA71-5C95-4633-8134-97E499AB719EQ33960580-90FF13F0-2F4B-4111-B5F9-B3D913AC4552Q34066752-14443BA9-F95C-4469-BD2F-7B4FA9BB635CQ34088790-0627A23C-8BB4-4FFF-8968-687B41379F51Q34124790-7B701A75-CD35-48DC-B913-9F94502FE88BQ34201543-95A4A0FB-5049-4B15-B0D5-40E481E651B3Q34264656-0D671A10-6BB1-4BE6-A57F-578502580702Q34362144-DB43C410-2C39-44C3-B8EB-D7B2206EF298Q34378293-1295F737-D2B2-4C38-AA28-30357BE45C4DQ34389782-5B8D2FCE-CF23-40B2-B726-5C95A2C6C7D4Q34463849-C12A7335-4D32-4341-B2A8-B09B9F0F9A88Q34464791-19361AAF-471C-47CD-B098-9FE0465FC1B3Q34551911-2244DE7D-3F00-4F9F-9CD3-D2138E202E70Q34573127-4CDF8E53-D7FC-4B4D-9A21-1F0A48C65DF7Q34803380-B5260671-417A-4379-8306-B9CABB5814D2Q34823543-5D903393-2C5C-44AF-AD12-622981BBE777Q35143901-0527C9B2-AAFF-4039-8FD9-FAB0E5342CDDQ35223944-67D1B31C-115F-4C02-B56B-D28782D506B2Q35299517-088706F4-22C7-42F2-991E-C3CF274FCC20Q35352722-B74DD5BB-2A83-414E-9F14-5C0E5745A473Q35394876-C45F8E94-D452-4EB2-92C3-E885AF4D0A39Q35599280-03CEA058-C938-420E-9362-C01DEAAB37A7Q35756665-8DB3568A-CFD3-4D2C-9E88-A11863C502E3Q35766342-777A3A7E-E23C-4F1D-B8F1-5C9D4B428B1EQ35854712-53DE5B3D-719A-4E3C-AC10-00AC6374147CQ36057329-C0B88DD2-076C-4281-94DA-640CE60FA675Q36078205-4D3A1D45-82EA-4C0B-856E-3838F651A432Q36124892-7B9ECF83-D14B-45FD-AA42-071141D6667D
P2860
Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Suppression of coronary artery ...... ients with vasospastic angina.
@en
Suppression of coronary artery ...... ients with vasospastic angina.
@nl
type
label
Suppression of coronary artery ...... ients with vasospastic angina.
@en
Suppression of coronary artery ...... ients with vasospastic angina.
@nl
prefLabel
Suppression of coronary artery ...... ients with vasospastic angina.
@en
Suppression of coronary artery ...... ients with vasospastic angina.
@nl
P2093
P356
P1433
P1476
Suppression of coronary artery ...... ients with vasospastic angina.
@en
P2093
Akihiro Masumoto
Akira Takeshita
Hiroaki Shimokawa
Lemmy Urakami
Makoto Usui
Masahiro Mohri
P304
P356
10.1161/HC1002.105938
P407
P577
2002-04-01T00:00:00Z